Old Web
English
Sign In
Acemap
>
Paper
>
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.
2021
Yu Bai
Fei Ye
Yong Feng
Hanyi Liao
Hao Song
Jianxun Qi
George F. Gao
Wenjie Tan
Lifeng Fu
Yi Shi
Keywords:
Narlaprevir
Protease
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Drug
Virology
Chemistry
anti hiv
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
5
Citations
NaN
KQI
[]